ALK-Abelló, also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacture of allergy immunotherapy products for the prevention and treatment of allergy.

Pharmaceutical

Peter Halling

Søren Niegel

Claus Steensen Sølje

Lika Thiesen

Judit Nyirady

Karine Duquenoy

Kristoffer Fog

Lene Christiansen

Jan Engel

Jacob Glenting

Jens Noack Skærbæk

Henriette Mersebach

Alan Main

Lene Skole

Gitte Aabo

Anders Hedegaard

Bertil Lindmark

Lars Holmqvist

Lise Lund Mærkedahl

Jesper Høiland

Johan Smedsrud

Nanna Carlson

Katja Barnkob

The Leadership Team at ALK plays a crucial role in steering the company's strategic direction and operational excellence. Comprising senior executives from key functional areas including finance, research and development, operations, marketing, and regulatory affairs, this team collaborates to innovate and enhance ALK's allergy immunotherapy products. They ensure alignment of corporate objectives, optimize resource allocation, and drive initiatives that foster growth and compliance within the pharmaceutical landscape.

Leadership Team

The Marketing and Sales team at ALK is dedicated to driving global commercial success for allergy immunotherapy products. This team focuses on developing and implementing strategic marketing initiatives, enhancing brand presence, and optimizing sales operations while ensuring effective communication with healthcare professionals and patients. By leveraging digital marketing and commercial excellence, they aim to increase market access and create impactful sales training programs, ultimately contributing to ALK's mission of improving allergy treatment outcomes worldwide.

Marketing and Sales

The Research and Development team at ALK focuses on advancing allergy immunotherapy products by conducting innovative research, developing and optimizing manufacturing processes, and overseeing clinical trials. This multidisciplinary team collaborates to enhance product efficacy and safety while ensuring regulatory compliance, ultimately contributing to improved treatment options for patients suffering from allergies.

Research and Development

The Financial Operations and Analysis team at ALK plays a critical role in driving the company’s financial performance by providing strategic financial insights and supporting decision-making processes. The team is responsible for corporate financial planning, budgeting, and forecasting, as well as ensuring compliance with IFRS standards. They also manage financial relationships across various business units, oversee accounting practices, and coordinate investor relations to align financial strategy with ALK’s mission of advancing allergy immunotherapy products.

Financial Operations and Analysis

The Regulatory Affairs and Compliance team at ALK is responsible for ensuring that all allergy immunotherapy products meet regulatory standards and compliance requirements across various markets. This team actively engages with regulatory agencies, oversees product submissions, and monitors adherence to safety and quality regulations, safeguarding patient safety and upholding the company’s commitment to high-quality healthcare solutions. Additionally, they support clinical trials and collaborate with internal stakeholders to drive regulatory strategy and ensure timely product approvals.

Regulatory Affairs and Compliance

ALK

Org chart

Board & advisors

Teams

Leadership Team

Marketing and Sales

Research and Development

Financial Operations and Analysis

Regulatory Affairs and Compliance

Offices

ALK

Org chart

Board & advisors

Teams

Leadership Team

Marketing and Sales

Research and Development

Financial Operations and Analysis

Regulatory Affairs and Compliance

Offices

Related companies